Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

By Dag Aarsland, K. Andersen, J. Larsen, A. Lolk, P. Kragh‐Sørensen. Archives of Neurology, 2003

1,428 citations recorded by the source corpus.

Subfields: Neurology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/52d0852ba7811fb7283b3733338b4782abd93dd5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

In Psychiatry and Mental health

Citations in the corpus

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. (2004, background): “Follow-up of prevalent cases has estimated that between 20% (Brown and Marsden, 1984) and 75% (Aarsland et al., 2003) of Parkinson's disease patients will ultimately develop dementia.”
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years (2008, background): “One had frontotemporal lobar degeneration with Pick bodies as well as PD.25”
Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines (2012, methodology): “To summarize, there are several differences between the diagnostic criteria proposed by the MDS and other established criteria, such as Petersen’s original MCI criteria: (1) MCI is defined within the context of an existing etiology, namely PD; (2) PD-MCI includes not just “memory” complaints, but al”
MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI (2011, background): “The point prevalence of PDD is approximately 30%,(75) and the cumulative prevalence is at least 75% for PD patients surviving more than 10 years.(2,3) As MCI precedes PDD, the cumulative prevalence of PDMCI must be at least as high as that of PDD.”
Rivastigmine for dementia associated with Parkinson's disease. (2004, background): “Recently, some authors have demonstrated a cumulative prevalence of dementia of 78% in a cohort of PD patients followed prospectively for 8 years [13].”
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. (2009, background): “Although Parkinson’s disease is classically defined as a movement disorder, cognitive abnormalities including dementia are a common feature (Aarsland et al., 2003) and have a major impact on quality of life (Schrag et al.”